Repetitive Speech Phenomena in Parkinson's Disease

Total Page:16

File Type:pdf, Size:1020Kb

Repetitive Speech Phenomena in Parkinson's Disease J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.3.319 on 1 September 2000. Downloaded from J Neurol Neurosurg Psychiatry 2000;69:319–325 319 Repetitive speech phenomena in Parkinson’s disease Th Benke, C Hohenstein, W Poewe, B Butterworth Abstract higher number of repetitive speech phe- Objectives—Repetitive speech phenom- nomena over semiautomatic forms of ena are morphologically heterogeneous speech. iterations of speech which have been Conclusions—In idiopathic Parkinson’s described in several neurological disor- disease repetitive speech phenomena ders such as vascular dementia, progres- seem to emerge predominantly in a sub- sive supranuclear palsy, Wilson’s disease, group of patients with advanced disease and Parkinson’s disease, and which are impairment; manifest dementia is not a presently only poorly understood. The necessary prerequisite. They seem to rep- present, prospective study investigated resent a deficit of motor speech control; repetitive speech phenomena in Parkin- however, linguistic factors may also con- son’s disease to describe their morphol- tribute to their generation. It is suggested ogy, assess their prevalence, and to that repetitions of speech in Parkinson’s establish their relation with neuropsycho- disease represent a distinctive speech dis- logical and clinical background data. order, which is caused by changes related Methods—Twenty four patients with ad- to the progression of Parkinson’s disease. vanced Parkinson’s disease and 29 sub- (J Neurol Neurosurg Psychiatry 2000;69:319–325) jects with mid-stage, stable idiopathic Keywords: Parkinson’s disease; repetitive speech phe- disease were screened for appearance, nomena forms, and frequency of repetitive speech phenomena, and underwent a neuro- psychological screening procedure com- Patients with Parkinson’s disease often present prising tests of general mental with a complex impairment of speech, com- functioning, divergent thinking and monly recognised as dysarthrophonia.1–6 It is memory. Patients with advanced Parkin- generally accepted that parkinsonian dysar- son’s disease had a significantly higher thria emerges due to neurogenic impairments disease impairment, longer disease dura- at the respiratory, phonatory, and articulatory tion, and an unstable motor response to level. Based on an earlier proposition by levodopa with frequent on-oV fluctua- Leyser,7 Critchley8 has classified the speech tions. Both groups were well matched as to disorders of patients with Parkinson’s disease their demographical, clinical, and cogni- into akinetic, rigid, hyperkinetic, and iterative tive background. Perceptual speech evalu- (or repetitive) forms of dysarthrophonia. This ation was used to count and diVerentiate symptomatic classification suggests that the http://jnnp.bmj.com/ forms of repetitive speech phenomena in two main elements of Parkinson’s disease, diVerent speech tasks. To compare the bradykinesia and rigidity, exert an influence on eVect of the motor state, the appearance of the motor speech system. The equivalents of repetitive speech phenomena was also hypokinesia or rigidity have been described as assessed in a subgroup of patients with monopitch, reduced stress, imprecisely pro- advanced Parkinson’s disease during the duced consonants, breathless voice, and on versus the oV state. monoloudness.1–356 Hyperkinesia has been Results—Speech repetitions emerged hypothesised to cause speech impairments on October 2, 2021 by guest. Protected copyright. mainly in two variants, one hyperfluent, such as voice harshness, excess loudness varia- University Clinic of formally resembling palilalia, and one tions, imprecise articulation, and disintegration Neurology, dysfluent, stuttering-like. Both forms 9 Anichstrasse 35, of respiratory processes. Iterative or repetitive A-6020 Innsbruck, were present in each patient producing speech phenomena are the least studied Austria repetitive speech phenomena. The repeti- features of the articulatory disorder in Parkin- Th Benke tive speech phenomena appeared in 15 son’s disease. Repetitive speech phenomena C Hohenstein patients (28.3 %), 13 of whom belonged to may be characterised broadly as a group of W Poewe the advanced disease group, indicating a variable speech iterations with immediately University College significant preponderance of repetitive successive repetitions of syllables, words, or London, UK speech phenomena in patients with a long phrases. Due to their heterogeneity, they have B Butterworth term, fluctuating disease course. Repeti- been labelled diVerently, as stuttering,10 speech tive speech phenomena appeared with iterations,11 or palilalia.12 13 With the exception Correspondence to: almost equal frequency during the on and of palilalia, which is a frequent sequel of Dr Thomas Benke 71415 [email protected] the oV state of patients with advanced postencephalitic Parkinson’s disease, the Parkinson’s disease. Their distribution phenomena are considered rare symptoms of Received 22 September 1999 among diVerent variants of speech was idiopathic Parkinson’s disease.4 However, only and in revised form 28 February 2000 disproportional, with eVort demanding few studies have undertaken a detailed search Accepted 12 April 2000 speech tasks producing a significantly for repetitive speech phenomena in Parkinson’s www.jnnp.com J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.3.319 on 1 September 2000. Downloaded from 320 Benke, Hohenstein, Poewe, et al disease. Koller10 studied six patients with memory, and constructional abilities17); a mul- parkinsonian symptoms who developed dysflu- tiple choice vocabulary test for the estimation ent, stuttering-like repetitions which were most of premorbid intelligence18; and two semantic pronounced in self formulated speech, aVected word list generation tasks (number of gener- initial phonemes more often, and were not ated animal names and supermarket items alleviated by levodopa therapy. Hertrich et al11 during a period of 60 seconds; perseverative described repetitive speech phenomena in a responses were subtracted from the total cognitively declined patient with Parkinson’s count). Short and long term retention of verbal disease appearing as predominantly monosyl- material was assessed using the story recall labic iterations occurring at all word positions. section of the Rivermead behavioural memory Ackermann et al4 noted a patient with idio- test.19 In all patients, motor ratings, speech pathic, late stage Parkinson’s disease with tasks, and neurobehavioural background tests on-oV fluctuations who developed palilalia were administered in the morning during the during peak dose hyperkinesia, pointing to a on state about 1 hour after drug administra- possible relation between the appearance of tion. repetitive speech phenomena and the drug induced on phase in long term Parkinson’s dis- PERCEPTUAL SPEECH EVALUATION ease. These studies have called attention to the It was the aim of this speech assessment to existence of repetitive speech phenomena in detect subjects with repetitive speech phenom- Parkinson’s disease and to possible influential ena, to evoke speech in diVerent categories of variables such as stage of disease, eVect of levo- natural language, and to characterise and dopa treatment, and cognitive background. count their repetitions on the basis of percep- However, due to the lack of data which have tual measurement. During the test procedure been derived systematically from a larger patients were seated in a quiet room. All patient population, the role of speech iterations patients received detailed instructions on how in Parkinson’s disease remains unclear. The to perform each test and were asked to speak present study was undertaken to describe the as slowly and distinctively as possible. Five characteristics of repetitive speech phenomena speech production tasks were tested. Patients in idiopathic Parkinson’s disease. More specifi- were asked to produce spontaneous speech cally, the aim was to describe the morphology during an extensive, semistructured interview of verbal iterations, to establish their preva- with questions regarding details of their lence in diVerent forms of the disease, and to disease, profession, family, and place of grow- evaluate their relation to neuropsychological ing up. Naming was evoked by having patients and clinical background data. describe the details of a complex scenic picture containing common objects. A reading test Patients and methods required reading aloud two short paragraphs PATIENTS of a prose text, both presented in large print on Fifty three patients with Parkinson’s disease an A4 sized sheet of paper; one paragraph were investigated in a prospective study contained normal words, whereas in the encompassing clinical, speech, and neuro- second passage 15% of all words had been psychological tasks. All patients were diag- changed to phonologically regular non-words. nosed according to UK Parkinson’s Disease Similarly, repetition of speech was tested using Society Brain Bank criteria.16 All patients had 15 words and four sentences, both of increas- two of the three cardinal signs (bradykinesia, ing length, taken from the Aachener http://jnnp.bmj.com/ rigidity, tremor) and showed no evidence of Aphasietest,20 and a corresponding section secondary parkinsonism due to antidopamin- using non-words and sentences containing ergic medication, or clinically relevant cer- neologisms. Automatic speech was assessed by ebrovascular disease. Additional criteria were asking patients to
Recommended publications
  • The Rigid Form of Huntington's Disease U
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.24.1.71 on 1 February 1961. Downloaded from J. Neurol. Neurosurg. Psychiat., 1961, 24, 71. THE RIGID FORM OF HUNTINGTON'S DISEASE BY A. M. G. CAMPBELL, BERYL CORNER, R. M. NORMAN, and H. URICH From the Department ofNeurosurgery and Child Health, Bristol Royal Hospital, and the Burden Neuropathological Laboratory, Frenchay Hospital, Bristol Although the majority of cases of hereditary genetic study of Entres (1925) to belong to a typical chorea correspond accurately to the classical pattern Huntington family. More recent contributions are described by Huntington (1872), a number of those of Rotter (1932), Hempel (1938), and atypical forms have been recorded in children and Lindenberg (1960). Bielschowsky (1922) gave a adults which are characterized by rigidity rather detailed account of the pathological findings in a than by hyperkinesia. Most of these have been patient who was choreic at the age of 6 years and reported in the continental literature and we thought from the age of 9 gradually developed Parkinsonian it was of interest to draw attention to two atypical rigidity. Our own juvenile case is remarkable in juvenile cases occurring in an English family. From Reisner's (1944) review of these juvenile U cases the fact emerges that although the majority A present with typical choreiform movements, two Protected by copyright. atypical variants also occur: one in which the clinical picture is that of progressive extrapyramidal BC rigidity without involuntary movements, the other in which the disease starts as a hyperkinetic syn- drome and gradually changes into a hypokinetic one with progressive rigidity.
    [Show full text]
  • Clinical Manifestation of Juvenile and Pediatric HD Patients: a Retrospective Case Series
    brain sciences Article Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series 1, , 2, 2 1 Jannis Achenbach * y, Charlotte Thiels y, Thomas Lücke and Carsten Saft 1 Department of Neurology, Huntington Centre North Rhine-Westphalia, St. Josef-Hospital Bochum, Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] 2 Department of Neuropaediatrics and Social Paediatrics, University Children’s Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] (C.T.); [email protected] (T.L.) * Correspondence: [email protected] These two authors contribute to this paper equally. y Received: 30 April 2020; Accepted: 1 June 2020; Published: 3 June 2020 Abstract: Background: Studies on the clinical manifestation and course of disease in children suffering from Huntington’s disease (HD) are rare. Case reports of juvenile HD (onset 20 years) describe ≤ heterogeneous motoric and non-motoric symptoms, often accompanied with a delay in diagnosis. We aimed to describe this rare group of patients, especially with regard to socio-medical aspects and individual or common treatment strategies. In addition, we differentiated between juvenile and the recently defined pediatric HD population (onset < 18 years). Methods: Out of 2593 individual HD patients treated within the last 25 years in the Huntington Centre, North Rhine-Westphalia (NRW), 32 subjects were analyzed with an early onset younger than 21 years (1.23%, juvenile) and 18 of them younger than 18 years of age (0.69%, pediatric). Results: Beside a high degree of school problems, irritability or aggressive behavior (62.5% of pediatric and 31.2% of juvenile cases), serious problems concerning the social and family background were reported in 25% of the pediatric cohort.
    [Show full text]
  • Restless Legs Syndrome: Keys to Recognition and Treatment
    REVIEW JAIME F. AVECILLAS, MD JOSEPH A. GOLISH, MD CARMEN GIANNINI, RN, BSN JOSÉ C. YATACO, MD Department of Pulmonary and Critical Department of Pulmonary and Critical Department of Pulmonary and Critical Care Department of Pulmonary and Critical Care Care Medicine, The Cleveland Clinic Care Medicine and Department of Medicine, The Cleveland Clinic Foundation Medicine, The Cleveland Clinic Foundation Foundation Neurology, The Cleveland Clinic Foundation Restless legs syndrome: Keys to recognition and treatment ■ ABSTRACT ESTLESS LEGS SYNDROME (RLS) is not a R new diagnosis: it was first described com- Restless legs syndrome (RLS) is a common and clinically prehensively 60 years ago.1 However, it con- significant motor disorder increasingly recognized by tinues to be underdiagnosed, underreported, physicians and the general public, yet still and undertreated. Effective therapies for this underdiagnosed, underreported, and undertreated. motor disorder are available, but a high index Effective therapies are available, but a high index of of suspicion is necessary to identify the condi- suspicion is required to make the diagnosis and start tion and start treatment in a timely fashion. treatment quickly. We now have enough data to support Evidence from clinical trials supports the the use of dopaminergic agents, benzodiazepines, use of dopaminergic agents, benzodiazepines, antiepileptics, and opioids in these patients. antiepileptics, and opioids in these patients. The clinician must be familiar with the benefits ■ KEY POINTS and risks of these therapies to be able to provide optimal treatment in patients with RLS. RLS is characterized by paresthesias, usually in the lower extremities. Patients often describe them as “achy” or ■ CLINICAL DEFINITION: “crawling” sensations.
    [Show full text]
  • Paroxysmal Hyperkinesia with Diurnal Fluctuations Due to Sepiapterin-Reductase Deficiency Tina Mainka, Jessica Hoffmann, Andrea A
    Published Ahead of Print on June 26, 2020 as 10.1212/WNL.0000000000009901 RESIDENT & FELLOW SECTION Teaching Video NeuroImages: Paroxysmal hyperkinesia with diurnal fluctuations due to sepiapterin-reductase deficiency Tina Mainka, MD, Jessica Hoffmann, Andrea A. Kuhn,¨ MD, Saskia Biskup, MD, and Christos Ganos, MD Correspondence Dr. Ganos Neurology 2020;95:1-e3. doi:10.1212/WNL.0000000000009901 ® [email protected] A 42-year-old man, born of consanguineous parents, presented with long-standing severe, MORE ONLINE nonepileptic jerky movements of the upper body, pronounced during the second half of the day Video and improving after sleep (video, A and B). There was a history of neurodevelopmental disorder with axial hypotonia, delayed milestones, intellectual disability, and poor speech Teaching slides production. The combination of a neurodevelopmental syndrome and a movement disorder links.lww.com/WNL/ with diurnal fluctuations1 led to targeted exome sequencing for monoamine metabolism dis- B131 orders. A homozygous nonsense variant in the SPR gene was identified (figure), confirmed by Sanger sequencing (figure). Treatment with levodopa led to marked improvement of abnormal movements (video, C). Acknowledgment The authors thank the patient for his participation and support. Study funding Academic research support from the VolkswagenStiftung (Freigeist Fellowship; C. Ganos). Disclosure T. Mainka, J. Hoffmann, A.A. K¨uhn,S. Biskup, and C. Ganos report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures. From the Department of Neurology (T.M., A.A.K., C.G.), Charit´e University Medicine Berlin; Berlin Institute of Health (T.M.); and Center for Genomics and Transcriptomics (J.H., S.B.), Tubingen,¨ Germany.
    [Show full text]
  • Hyperpolarization of the Subthalamic Nucleus Alleviates Hyperkinetic
    www.nature.com/scientificreports OPEN Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders Chun-Hwei Tai1, Ming-Kai Pan 2, Sheng-Hong Tseng3, Tien-Rei Wang1 & Chung-Chin Kuo1,4 ✉ Modulation of subthalamic nucleus (STN) fring patterns with injections of depolarizing currents into the STN is an important advance for the treatment of hypokinetic movement disorders, especially Parkinson’s disease (PD). Chorea, ballism and dystonia are prototypical examples of hyperkinetic movement disorders. In our previous study, normal rats without nigro-striatal lesion were rendered hypokinetic with hyperpolarizing currents injected into the STN. Therefore, modulation of the fring pattern by injection of a hyperpolarizing current into the STN could be an efective treatment for hyperkinetic movement disorders. We investigated the efect of injecting a hyperpolarizing current into the STNs of two diferent types of hyperkinetic animal models and a patient with an otherwise uncontrollable hyperkinetic disorder. The two animal models included levodopa-induced hyperkinetic movement in parkinsonian rats (L-DOPA-induced dyskinesia model) and hyperkinesia induced by an intrastriatal injection of 3-nitropropionic acid (Huntington disease model), covering neurodegeneration- related as well as neurotoxin-induced derangement in the cortico-subcortical re-entrant loops. Delivering hyperpolarizing currents into the STN readily alleviated the hyperkinetic behaviors in the two animal models and in the clinical case, with an evident increase in subthalamic burst discharges in electrophysiological recordings. Application of a hyperpolarizing current into the STN via a Deep brain stimulation (DBS) electrode could be an efective general therapy for a wide spectrum of hyperkinetic movement disorders. Movement disorders may be divided into two broad categories: hypokinetic and hyperkinetic.
    [Show full text]
  • Hemiballismus: /Etiology and Surgical Treatment by Russell Meyers, Donald B
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.13.2.115 on 1 May 1950. Downloaded from J. Neurol. Neurosurg. Psychiat., 1950, 13, 115. HEMIBALLISMUS: /ETIOLOGY AND SURGICAL TREATMENT BY RUSSELL MEYERS, DONALD B. SWEENEY, and JESS T. SCHWIDDE From the Division of Neurosurgery, State University of Iowa, College ofMedicine, Iowa City, Iowa Hemiballismus is a relatively uncommon hyper- 1949; Whittier). A few instances are on record in kinesia characterized by vigorous, extensive, and which the disorder has run an extended chronic rapidly executed, non-patterned, seemingly pur- course (Touche, 1901 ; Marcus and Sjogren, 1938), poseless movements involving one side of the body. while in one case reported by Lea-Plaza and Uiberall The movements are almost unceasing during the (1945) the abnormal movements are said to have waking state and, as with other hyperkinesias con- ceased spontaneously after seven weeks. Hemi- sidered to be of extrapyramidal origin, they cease ballismus has also been known to cease following during sleep. the supervention of a haemorrhagic ictus. Clinical Aspects Terminology.-There appears to be among writers on this subject no agreement regarding the precise Cases are on record (Whittier, 1947) in which the Protected by copyright. abnormal movements have been confined to a single features of the clinical phenomena to which the limb (" monoballismus ") or to both limbs of both term hemiballismus may properly be applied. sides (" biballismus ") (Martin and Alcock, 1934; Various authors have credited Kussmaul and Fischer von Santha, 1932). In a majority of recorded (1911) with introducing the term hemiballismus to instances, however, the face, neck, and trunk as well signify the flinging or flipping character of the limb as the limbs appear to have been involved.
    [Show full text]
  • Motor Systems Basal Ganglia
    Motor systems 409 Basal Ganglia You have just read about the different motor-related cortical areas. Premotor areas are involved in planning, while MI is involved in execution. What you don’t know is that the cortical areas involved in movement control need “help” from other brain circuits in order to smoothly orchestrate motor behaviors. One of these circuits involves a group of structures deep in the brain called the basal ganglia. While their exact motor function is still debated, the basal ganglia clearly regulate movement. Without information from the basal ganglia, the cortex is unable to properly direct motor control, and the deficits seen in Parkinson’s and Huntington’s disease and related movement disorders become apparent. Let’s start with the anatomy of the basal ganglia. The important “players” are identified in the adjacent figure. The caudate and putamen have similar functions, and we will consider them as one in this discussion. Together the caudate and putamen are called the neostriatum or simply striatum. All input to the basal ganglia circuit comes via the striatum. This input comes mainly from motor cortical areas. Notice that the caudate (L. tail) appears twice in many frontal brain sections. This is because the caudate curves around with the lateral ventricle. The head of the caudate is most anterior. It gives rise to a body whose “tail” extends with the ventricle into the temporal lobe (the “ball” at the end of the tail is the amygdala, whose limbic functions you will learn about later). Medial to the putamen is the globus pallidus (GP).
    [Show full text]
  • EXTRAPYRAMIDAL MOVEMENT DISORDERS (GENERAL) Mov1 (1)
    EXTRAPYRAMIDAL MOVEMENT DISORDERS (GENERAL) Mov1 (1) Extrapyramidal Movement Disorders (GENERAL) Last updated: July 12, 2019 PATHOPHYSIOLOGY ..................................................................................................................................... 1 CLINICAL FEATURES .................................................................................................................................... 2 DIAGNOSIS ................................................................................................................................................... 3 TREATMENT ................................................................................................................................................. 4 MORPHOLOGIC CORRELATIONS ................................................................................................................... 4 TREMOR ......................................................................................................................................................... 5 ESSENTIAL TREMOR ..................................................................................................................................... 6 ORTHOSTATIC TREMOR ................................................................................................................................ 7 PRIMARY WRITER'S TREMOR ........................................................................................................................ 7 PHYSIOLOGIC TREMOR ................................................................................................................................
    [Show full text]
  • Cytosolic Non-Vesicular Dopamine Accumulation As the Predominant Mechanism for Developing Non-DOPA Responsive Parkinsonism in Late-Stage T Huntington Disease
    Medical Hypotheses 132 (2019) 109377 Contents lists available at ScienceDirect Medical Hypotheses journal homepage: www.elsevier.com/locate/mehy Cytosolic non-vesicular dopamine accumulation as the predominant mechanism for developing non-DOPA responsive parkinsonism in late-stage T Huntington disease Rafael Vincent M. Manalo College of Medicine, University of the Philippines Manila, Ermita, Manila 1000, Philippines ARTICLE INFO ABSTRACT Keywords: Disturbances in motor movement can have similar clinical presentations, albeit having different pathways and Chorea temporal onset. Hypokinetic movements present with rigidity, resting tremors, postural instability and brady- Dyskinesia kinesia, as seen in parkinsonism, while hyperkinetic movements typically present with chorea, ballismus, tic, Nigrostriatal pathway athetosis and dystonia. Nonetheless, movement disorders are thought to be a continuum. Long-term therapy of GABA parkinsonism with L-DOPA or dopamine (DA) agonists leads to late-onset dyskinesia – a hyperkinetic movement Glutamate excitotoxicity disorder, while patients with late-stage Huntington disease (HD) often develop non-DOPA responsive parkin- Substantia nigra sonism. In this paper, it is proposed that late-onset parkinsonism is driven by the overactivity of the nigrostriatal dopaminergic pathway. The excessive synthesis, storage, release, reuptake and degradation of dopamine in the presynaptic terminal and synaptic clefts lead to cellular stress and damage, resulting to progressive neuroa- poptosis aggravated by pro-parkinsonism drugs used to treat hyperkinesia. Glutamate excitotoxicity may provide initial stress to neurons during early HD – but as the disease advances, lower glutamate levels are observed, making it less likely to cause the hypokinetic shift on its own. Over time, dopaminergic neurons are depleted and cholinergic influence to striatal GABA release is unopposed, leading to late-onset parkinsonism that is un- responsive to DOPA challenge, due to drastic DA neuron loss previously masked by the dominating choreic presentation.
    [Show full text]
  • Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias
    International Journal of Molecular Sciences Review Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias Giacomo Garone 1,2 , Alessandro Capuano 2 , Lorena Travaglini 3,4 , Federica Graziola 2,5 , Fabrizia Stregapede 4,6, Ginevra Zanni 3,4, Federico Vigevano 7, Enrico Bertini 3,4 and Francesco Nicita 3,4,* 1 University Hospital Pediatric Department, IRCCS Bambino Gesù Children’s Hospital, University of Rome Tor Vergata, 00165 Rome, Italy; [email protected] 2 Movement Disorders Clinic, Neurology Unit, Department of Neuroscience and Neurorehabilitation, IRCCS Bambino Gesù Children’s Hospital, 00146 Rome, Italy; [email protected] (A.C.); [email protected] (F.G.) 3 Unit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience and Neurorehabilitation, IRCCS Bambino Gesù Children’s Hospital, 00146 Rome, Italy; [email protected] (L.T.); [email protected] (G.Z.); [email protected] (E.B.) 4 Laboratory of Molecular Medicine, IRCCS Bambino Gesù Children’s Hospital, 00146 Rome, Italy; [email protected] 5 Department of Neuroscience, University of Rome Tor Vergata, 00133 Rome, Italy 6 Department of Sciences, University of Roma Tre, 00146 Rome, Italy 7 Neurology Unit, Department of Neuroscience and Neurorehabilitation, IRCCS Bambino Gesù Children’s Hospital, 00165 Rome, Italy; [email protected] * Correspondence: [email protected]; Tel.: +0039-06-68592105 Received: 30 April 2020; Accepted: 13 May 2020; Published: 20 May 2020 Abstract: Paroxysmal movement disorders (PMDs) are rare neurological diseases typically manifesting with intermittent attacks of abnormal involuntary movements. Two main categories of PMDs are recognized based on the phenomenology: Paroxysmal dyskinesias (PxDs) are characterized by transient episodes hyperkinetic movement disorders, while attacks of cerebellar dysfunction are the hallmark of episodic ataxias (EAs).
    [Show full text]
  • Movement Disorders and Frontotemporal Dementia
    8/17/2017 Movement Disorders and Frontotemporal Dementia Michael K. Cooper Neuropsychiatry Conference September 8, 2017 Samantha Holden, MD Assistant Professor of Neurology Movement Disorders and FTD • FTD can present with various hyperkinetic or hypokinetic movements – Abnormal movements can precede, coincide or follow cognitive impairments • Clinical overlap diagnostic challenges • No clear clinical-pathological correlations Classification of FTLD by Clinical Manifestations Park et al 2013 1 8/17/2017 Movement Disorders and FTD Baizabal-Carvallo et al 2016 MD and FTD: Pathophysiology • Loss of afferent input from frontal cortex to subcortical gray matter – Dorsolateral and dorsomedial frontal cortices project to central band in striatum – Anterior cingulate, orbitofrontal and temporal polar cortices project to medial striatum and nucleus accumbens MD and FTD: Pathophysiology • Basal ganglia volume loss in FTLD – bvFTD: 25% loss – nfPPA: 21% loss – svPPA: 8% loss Looi et al 2008 2 8/17/2017 MD and FTD: Clinical Phenotypes Hypokinetic: Hyperkinetic: • Parkinsonism • Stereotypies • Primary freezing of gait • Chorea • Progressive supranuclear palsy • Dystonia • Corticobasal syndrome • Myoclonus • Multiple system atrophy • Dementia with Lewy bodies MD and FTD: Genetics • Various genetic mutations underlie mixed presentations – No direct genotype-phenotype correlations • FTD and parkinsonism linked to chromosome 17 (FTDP-17) – Term introduced at international consensus conference in 1996 FTDP-17 • By 1996, 13 families described with autosomal
    [Show full text]
  • Evidence of Thalamic Disinhibition in Patients with Hemichorea
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.72.3.329 on 1 March 2002. Downloaded from 329 PAPER Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT J-S Kim, K-S Lee, K-H Lee, Y-I Kim, B-S Kim, Y-A Chung, S-K Chung ............................................................................................................................. J Neurol Neurosurg Psychiatry 2002;72:329–333 Objectives: Hemichorea sometimes occurs after lesions that selectively involve the caudate nucleus, putamen, and globus pallidus. Some reports have hypothesised that the loss of subthalamic nucleus control on the internal segment of the globus pallidus, followed by the disinhibition of the thalamus may contribute to chorea. However, the pathophysiology is poorly understood. Therefore, clinicoradiologi- cal localisation was evaluated and a comparison of the haemodynamic status of the basal ganglia and See end of article for thalamus was made. authors’ affiliations Methods: Six patients presenting with acute onset of hemichorea were assessed. Neuroimaging stud- ....................... ies, including MRI and SPECT examinations in addition to detailed biochemical tests, were performed. Correspondence to: A semiquantitative analysis was performed by comparing the ratio of blood flow between patients and Dr K-S Lee, Movement normal controls. In addition, the ratio of perfusion asymmetry was calculated as the ratio between each Clinic, Department of Neurology, Kangnam St area contralateral to the chorea and that homolateral to the chorea. The comparison was made with a Mary’s Hospital, 505 two sample t test. Banpo-Dong, Seocho-Ku, Results: The causes of hemichorea found consisted of four cases of acute stroke, one non-ketotic Seoul, 130–701, South hyperglycaemia, and one systemic lupus erythematosus.
    [Show full text]